Cerevel Therapeutics Holdings, Inc. Quarterly Return On Assets in % from Q1 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q1 2024.
  • Cerevel Therapeutics Holdings, Inc. Return On Assets for the quarter ending March 31, 2024 was -45.1 %, a 5.8% decline year-over-year.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Assets for 2023 was -44.5 %, a 5.3% decline from 2022.
  • Cerevel Therapeutics Holdings, Inc. annual Return On Assets for 2022 was -42.3 %, a 4.17% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -45.1 -2.47 -5.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.5 -2.24 -5.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.9 -0.5 -1.18% Jul 1, 2023 Sep 30, 2023
Q2 2023 -40.3 +2.15 +5.07% Apr 1, 2023 Jun 30, 2023
Q1 2023 -42.6 -2.69 -6.74% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42.3 -1.69 -4.17% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.4 -2.06 -5.11% Jul 1, 2022 Sep 30, 2022
Q2 2022 -42.4 +8.15 +16.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -39.9 +12 +23.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.6 Oct 1, 2021 Dec 31, 2021
Q3 2021 -40.3 Jul 1, 2021 Sep 30, 2021
Q2 2021 -50.6 Apr 1, 2021 Jun 30, 2021
Q1 2021 -51.9 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.